| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Pesticides | 9 | 2020 | 100 | 4.67 | Why? |
| Complex Mixtures | 5 | 2019 | 51 | 3.09 | Why? |
| Food Contamination | 5 | 2019 | 142 | 2.32 | Why? |
| Toxicity Tests | 4 | 2018 | 100 | 1.67 | Why? |
| Toxicity Tests, Chronic | 2 | 2019 | 6 | 1.64 | Why? |
| Extracellular Matrix | 4 | 2019 | 189 | 1.61 | Why? |
| Cadmium | 4 | 2020 | 105 | 1.55 | Why? |
| Hazardous Substances | 2 | 2020 | 76 | 1.54 | Why? |
| Toxicology | 2 | 2018 | 52 | 1.38 | Why? |
| Mutagens | 2 | 2018 | 38 | 1.35 | Why? |
| Plants, Genetically Modified | 2 | 2017 | 84 | 1.34 | Why? |
| Nitro Compounds | 2 | 2018 | 190 | 1.21 | Why? |
| No-Observed-Adverse-Effect Level | 4 | 2019 | 15 | 1.21 | Why? |
| Insecticides | 2 | 2018 | 178 | 1.17 | Why? |
| Environmental Pollutants | 3 | 2019 | 320 | 1.12 | Why? |
| DNA Damage | 2 | 2016 | 285 | 1.07 | Why? |
| Amyotrophic Lateral Sclerosis | 3 | 2018 | 398 | 1.06 | Why? |
| Water Pollutants, Chemical | 3 | 2019 | 410 | 1.05 | Why? |
| Xenobiotics | 2 | 2020 | 37 | 1.04 | Why? |
| Micronucleus Tests | 2 | 2019 | 12 | 1.02 | Why? |
| Food Additives | 2 | 2019 | 27 | 1.00 | Why? |
| Micronuclei, Chromosome-Defective | 2 | 2019 | 8 | 1.00 | Why? |
| Hormesis | 2 | 2019 | 30 | 0.96 | Why? |
| Polyphenols | 3 | 2020 | 283 | 0.91 | Why? |
| Neonicotinoids | 2 | 2018 | 14 | 0.90 | Why? |
| Endocrine Disruptors | 2 | 2018 | 50 | 0.88 | Why? |
| Maze Learning | 2 | 2019 | 35 | 0.86 | Why? |
| Imidazoles | 2 | 2017 | 631 | 0.86 | Why? |
| Diet, Carbohydrate-Restricted | 1 | 2020 | 36 | 0.84 | Why? |
| Metals, Heavy | 2 | 2020 | 147 | 0.83 | Why? |
| Fatty Acids, Unsaturated | 1 | 2020 | 70 | 0.82 | Why? |
| Avitaminosis | 1 | 2019 | 20 | 0.81 | Why? |
| Aquaculture | 1 | 2019 | 12 | 0.80 | Why? |
| Polychlorinated Biphenyls | 1 | 2019 | 14 | 0.80 | Why? |
| Mushroom Poisoning | 1 | 2019 | 10 | 0.80 | Why? |
| Fish Products | 1 | 2018 | 9 | 0.79 | Why? |
| Nanoparticles | 5 | 2019 | 2040 | 0.79 | Why? |
| Seafood | 2 | 2019 | 103 | 0.79 | Why? |
| Beverages | 2 | 2017 | 87 | 0.78 | Why? |
| Animals | 49 | 2021 | 78931 | 0.78 | Why? |
| Dietary Exposure | 1 | 2019 | 27 | 0.78 | Why? |
| Snails | 1 | 2018 | 18 | 0.78 | Why? |
| Irritants | 2 | 2019 | 28 | 0.78 | Why? |
| Hair | 2 | 2018 | 175 | 0.76 | Why? |
| Lead | 2 | 2020 | 94 | 0.76 | Why? |
| Organophosphates | 2 | 2018 | 66 | 0.76 | Why? |
| Mercury | 2 | 2020 | 95 | 0.76 | Why? |
| Tungsten Compounds | 1 | 2018 | 3 | 0.76 | Why? |
| Aldehyde Oxidase | 1 | 2018 | 10 | 0.75 | Why? |
| Behavior, Animal | 2 | 2018 | 136 | 0.75 | Why? |
| Caprylates | 1 | 2018 | 35 | 0.75 | Why? |
| Aryldialkylphosphatase | 1 | 2018 | 61 | 0.74 | Why? |
| Fishes | 1 | 2019 | 99 | 0.74 | Why? |
| Triclosan | 1 | 2018 | 17 | 0.74 | Why? |
| Dermatitis, Allergic Contact | 2 | 2019 | 185 | 0.74 | Why? |
| Avoidance Learning | 1 | 2019 | 99 | 0.72 | Why? |
| Electronic Nicotine Delivery Systems | 4 | 2019 | 561 | 0.72 | Why? |
| Muscles | 1 | 2018 | 152 | 0.71 | Why? |
| Fatty Acids | 2 | 2018 | 238 | 0.70 | Why? |
| Food, Genetically Modified | 1 | 2017 | 11 | 0.70 | Why? |
| Hydrocarbons, Chlorinated | 1 | 2017 | 11 | 0.69 | Why? |
| Health | 1 | 2018 | 130 | 0.69 | Why? |
| Abnormalities, Drug-Induced | 1 | 2018 | 72 | 0.68 | Why? |
| Fluorocarbons | 1 | 2018 | 102 | 0.67 | Why? |
| Polycyclic Aromatic Hydrocarbons | 1 | 2017 | 30 | 0.67 | Why? |
| Carbonated Beverages | 1 | 2017 | 45 | 0.66 | Why? |
| Animal Feed | 1 | 2017 | 72 | 0.66 | Why? |
| Delayed-Action Preparations | 1 | 2019 | 291 | 0.65 | Why? |
| Environmental Exposure | 8 | 2020 | 1558 | 0.65 | Why? |
| Rats, Sprague-Dawley | 5 | 2019 | 987 | 0.64 | Why? |
| Zebrafish | 1 | 2017 | 181 | 0.63 | Why? |
| Legislation, Drug | 1 | 2017 | 101 | 0.63 | Why? |
| Congenital Abnormalities | 1 | 2018 | 170 | 0.62 | Why? |
| Memory, Short-Term | 1 | 2017 | 137 | 0.62 | Why? |
| Phenols | 1 | 2018 | 226 | 0.62 | Why? |
| Marijuana Abuse | 1 | 2017 | 111 | 0.60 | Why? |
| Digestive System Diseases | 1 | 2020 | 378 | 0.60 | Why? |
| Allergens | 2 | 2019 | 728 | 0.59 | Why? |
| Energy Metabolism | 1 | 2019 | 451 | 0.57 | Why? |
| Benzhydryl Compounds | 1 | 2018 | 240 | 0.57 | Why? |
| Cannabinoids | 1 | 2017 | 134 | 0.57 | Why? |
| Blood-Brain Barrier | 1 | 2019 | 531 | 0.56 | Why? |
| Inflammation | 5 | 2020 | 13255 | 0.55 | Why? |
| Metabolic Diseases | 1 | 2020 | 505 | 0.55 | Why? |
| Cytochrome P-450 CYP1A1 | 3 | 2018 | 39 | 0.55 | Why? |
| Polymorphism, Genetic | 2 | 2018 | 1074 | 0.54 | Why? |
| Contrast Media | 2 | 2017 | 1011 | 0.54 | Why? |
| Metabolome | 1 | 2018 | 624 | 0.53 | Why? |
| Environment | 2 | 2017 | 769 | 0.53 | Why? |
| Oxidative Stress | 8 | 2019 | 2050 | 0.53 | Why? |
| Flavones | 3 | 2018 | 65 | 0.53 | Why? |
| Diet | 4 | 2020 | 2052 | 0.52 | Why? |
| Dose-Response Relationship, Drug | 7 | 2019 | 3776 | 0.51 | Why? |
| Dog Diseases | 1 | 2020 | 745 | 0.51 | Why? |
| Epidemiologic Methods | 1 | 2017 | 392 | 0.50 | Why? |
| Chromatography, High Pressure Liquid | 1 | 2017 | 669 | 0.50 | Why? |
| Risk Reduction Behavior | 1 | 2020 | 946 | 0.49 | Why? |
| Cannabis | 1 | 2017 | 284 | 0.49 | Why? |
| Metabolomics | 1 | 2018 | 921 | 0.48 | Why? |
| Psychotropic Drugs | 1 | 2017 | 396 | 0.47 | Why? |
| Immune System | 3 | 2020 | 1479 | 0.47 | Why? |
| Kidney Diseases | 2 | 2020 | 1434 | 0.46 | Why? |
| Nervous System Diseases | 2 | 2020 | 4092 | 0.44 | Why? |
| Noncommunicable Diseases | 1 | 2020 | 934 | 0.42 | Why? |
| Greece | 6 | 2019 | 2091 | 0.40 | Why? |
| Environmental Monitoring | 3 | 2018 | 3143 | 0.39 | Why? |
| Cytochrome P-450 CYP1B1 | 2 | 2018 | 10 | 0.37 | Why? |
| Gastrointestinal Microbiome | 2 | 2019 | 1961 | 0.37 | Why? |
| Mycobacterium tuberculosis | 1 | 2018 | 1164 | 0.37 | Why? |
| Syndecan-2 | 2 | 2017 | 4 | 0.37 | Why? |
| Fibrosarcoma | 2 | 2017 | 9 | 0.36 | Why? |
| Biosensing Techniques | 3 | 2021 | 2116 | 0.35 | Why? |
| Sex Factors | 4 | 2019 | 11014 | 0.34 | Why? |
| Brain Diseases | 1 | 2019 | 1463 | 0.32 | Why? |
| Hyaluronic Acid | 2 | 2019 | 168 | 0.32 | Why? |
| Gas Chromatography-Mass Spectrometry | 4 | 2019 | 187 | 0.32 | Why? |
| Schizophrenia | 1 | 2017 | 1018 | 0.32 | Why? |
| Lung Diseases | 1 | 2020 | 2361 | 0.32 | Why? |
| Neoplasms | 7 | 2020 | 17251 | 0.32 | Why? |
| Nicotine | 2 | 2019 | 213 | 0.31 | Why? |
| Signal Transduction | 9 | 2020 | 7207 | 0.31 | Why? |
| Eating | 2 | 2019 | 395 | 0.31 | Why? |
| Time | 2 | 2020 | 631 | 0.31 | Why? |
| Humans | 83 | 2021 | 930598 | 0.31 | Why? |
| Dietary Supplements | 5 | 2019 | 2251 | 0.30 | Why? |
| Rats | 5 | 2019 | 2764 | 0.30 | Why? |
| MicroRNAs | 1 | 2018 | 1787 | 0.30 | Why? |
| Air Pollutants | 2 | 2020 | 3110 | 0.29 | Why? |
| Rabbits | 3 | 2018 | 1171 | 0.29 | Why? |
| Risk Assessment | 11 | 2019 | 25439 | 0.27 | Why? |
| Antigens, Viral | 1 | 2021 | 6298 | 0.26 | Why? |
| Curcumin | 2 | 2020 | 396 | 0.26 | Why? |
| Obesity | 3 | 2020 | 7388 | 0.26 | Why? |
| Tissue Plasminogen Activator | 2 | 2021 | 778 | 0.26 | Why? |
| Weight Gain | 2 | 2019 | 552 | 0.26 | Why? |
| Anabolic Agents | 2 | 2019 | 49 | 0.24 | Why? |
| Time Factors | 8 | 2020 | 31397 | 0.24 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.23 | Why? |
| Inactivation, Metabolic | 2 | 2018 | 16 | 0.23 | Why? |
| Diet, Mediterranean | 2 | 2020 | 351 | 0.23 | Why? |
| Tuberculosis | 1 | 2018 | 2895 | 0.23 | Why? |
| Coronary Artery Disease | 1 | 2016 | 2570 | 0.23 | Why? |
| Cell Survival | 4 | 2019 | 1581 | 0.23 | Why? |
| Mass Spectrometry | 2 | 2018 | 1165 | 0.22 | Why? |
| DNA | 2 | 2018 | 778 | 0.22 | Why? |
| Oxidation-Reduction | 3 | 2019 | 540 | 0.22 | Why? |
| Heavy Metal Poisoning | 1 | 2020 | 17 | 0.22 | Why? |
| Drug Repositioning | 1 | 2020 | 5683 | 0.22 | Why? |
| Virus Internalization | 1 | 2020 | 7921 | 0.22 | Why? |
| Diminazene | 1 | 2020 | 24 | 0.22 | Why? |
| Pancreatic Neoplasms | 2 | 2019 | 609 | 0.22 | Why? |
| Colorectal Neoplasms | 3 | 2019 | 1884 | 0.22 | Why? |
| Gene Expression Regulation, Neoplastic | 2 | 2017 | 1014 | 0.22 | Why? |
| Government Regulation | 2 | 2019 | 842 | 0.22 | Why? |
| Cell Proliferation | 5 | 2019 | 1973 | 0.21 | Why? |
| Consumer Product Safety | 2 | 2019 | 57 | 0.21 | Why? |
| Melanins | 1 | 2020 | 42 | 0.21 | Why? |
| Rats, Wistar | 2 | 2019 | 621 | 0.21 | Why? |
| Gabexate | 1 | 2020 | 88 | 0.21 | Why? |
| Simvastatin | 1 | 2020 | 63 | 0.21 | Why? |
| Drug Delivery Systems | 3 | 2019 | 1365 | 0.21 | Why? |
| Dietary Fiber | 1 | 2020 | 73 | 0.21 | Why? |
| Neurodegenerative Diseases | 2 | 2019 | 469 | 0.21 | Why? |
| Homeostasis | 3 | 2019 | 582 | 0.21 | Why? |
| Cadmium Chloride | 1 | 2019 | 4 | 0.20 | Why? |
| Breast Neoplasms | 5 | 2018 | 3633 | 0.20 | Why? |
| Pistacia | 1 | 2019 | 5 | 0.20 | Why? |
| Cuminum | 1 | 2019 | 2 | 0.20 | Why? |
| Neuropharmacology | 1 | 2019 | 2 | 0.20 | Why? |
| Pesticide Residues | 1 | 2019 | 13 | 0.20 | Why? |
| Nuts | 1 | 2019 | 22 | 0.20 | Why? |
| Arylsulfatases | 1 | 2019 | 2 | 0.20 | Why? |
| Appetite Regulation | 1 | 2019 | 14 | 0.20 | Why? |
| Indenes | 1 | 2019 | 31 | 0.20 | Why? |
| Occupational Exposure | 2 | 2018 | 4742 | 0.20 | Why? |
| Product Labeling | 1 | 2019 | 41 | 0.20 | Why? |
| Bass | 1 | 2018 | 2 | 0.20 | Why? |
| Blepharospasm | 1 | 2019 | 5 | 0.20 | Why? |
| Sea Bream | 1 | 2018 | 3 | 0.20 | Why? |
| Cytotoxins | 1 | 2019 | 57 | 0.20 | Why? |
| Carbon Monoxide Poisoning | 1 | 2019 | 24 | 0.20 | Why? |
| Bread | 1 | 2019 | 14 | 0.20 | Why? |
| Poisons | 1 | 2019 | 26 | 0.20 | Why? |
| Acrylamide | 1 | 2019 | 24 | 0.20 | Why? |
| Hepatopancreas | 1 | 2018 | 1 | 0.20 | Why? |
| Hesperidin | 1 | 2019 | 48 | 0.20 | Why? |
| Toxins, Biological | 1 | 2019 | 40 | 0.20 | Why? |
| Polyesters | 1 | 2019 | 94 | 0.19 | Why? |
| Drinking | 1 | 2019 | 69 | 0.19 | Why? |
| Microcystins | 1 | 2018 | 5 | 0.19 | Why? |
| Chlorpromazine | 1 | 2020 | 130 | 0.19 | Why? |
| Antineoplastic Agents | 4 | 2019 | 3550 | 0.19 | Why? |
| Chromatography, Liquid | 3 | 2019 | 640 | 0.19 | Why? |
| Telomere Homeostasis | 1 | 2019 | 52 | 0.19 | Why? |
| Triticum | 1 | 2019 | 54 | 0.19 | Why? |
| Agaricales | 1 | 2019 | 38 | 0.19 | Why? |
| Receptor, Angiotensin, Type 1 | 1 | 2020 | 160 | 0.19 | Why? |
| Bromhexine | 1 | 2020 | 120 | 0.19 | Why? |
| Flavoring Agents | 1 | 2018 | 20 | 0.19 | Why? |
| Crops, Agricultural | 1 | 2019 | 88 | 0.19 | Why? |
| Fluorouracil | 1 | 2019 | 169 | 0.19 | Why? |
| Drinking Behavior | 1 | 2018 | 5 | 0.19 | Why? |
| Amiodarone | 1 | 2020 | 110 | 0.19 | Why? |
| Plant Roots | 1 | 2019 | 108 | 0.19 | Why? |
| Cardiotoxins | 1 | 2018 | 22 | 0.19 | Why? |
| Seeds | 1 | 2019 | 114 | 0.18 | Why? |
| Vaccine Potency | 1 | 2020 | 339 | 0.18 | Why? |
| Viral Vaccines | 1 | 2020 | 7560 | 0.18 | Why? |
| Eicosanoids | 1 | 2018 | 64 | 0.18 | Why? |
| Neoplasms, Experimental | 1 | 2018 | 67 | 0.18 | Why? |
| Nerve Agents | 1 | 2017 | 2 | 0.18 | Why? |
| Keratinocytes | 1 | 2019 | 119 | 0.18 | Why? |
| Cytochrome P-450 CYP1A2 | 1 | 2017 | 25 | 0.18 | Why? |
| Clinical Trials as Topic | 5 | 2020 | 7330 | 0.18 | Why? |
| Receptors, Aryl Hydrocarbon | 1 | 2020 | 152 | 0.18 | Why? |
| Proteoglycans | 1 | 2019 | 130 | 0.18 | Why? |
| Pyrrolidinones | 1 | 2018 | 66 | 0.18 | Why? |
| Food Analysis | 1 | 2018 | 53 | 0.18 | Why? |
| Doping in Sports | 1 | 2018 | 45 | 0.18 | Why? |
| Tubulin Modulators | 1 | 2019 | 126 | 0.18 | Why? |
| Human Experimentation | 1 | 2020 | 146 | 0.18 | Why? |
| Mitogen-Activated Protein Kinase 1 | 1 | 2017 | 43 | 0.18 | Why? |
| Mitogen-Activated Protein Kinase 3 | 1 | 2017 | 44 | 0.18 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.18 | Why? |
| Esters | 1 | 2020 | 300 | 0.18 | Why? |
| Organophosphorus Compounds | 1 | 2017 | 53 | 0.18 | Why? |
| Cholestasis | 1 | 2019 | 114 | 0.18 | Why? |
| Iohexol | 1 | 2017 | 42 | 0.18 | Why? |
| Drug Compounding | 1 | 2020 | 386 | 0.17 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.17 | Why? |
| Thiobarbituric Acid Reactive Substances | 2 | 2019 | 20 | 0.17 | Why? |
| Cytoskeletal Proteins | 1 | 2017 | 63 | 0.17 | Why? |
| Reproducibility of Results | 3 | 2019 | 11304 | 0.17 | Why? |
| Oils, Volatile | 1 | 2019 | 127 | 0.17 | Why? |
| Telomere | 1 | 2019 | 146 | 0.17 | Why? |
| Acetic Acid | 1 | 2017 | 50 | 0.17 | Why? |
| Carcinogenesis | 1 | 2019 | 236 | 0.17 | Why? |
| European Union | 2 | 2019 | 565 | 0.17 | Why? |
| Cell Line, Tumor | 7 | 2019 | 3608 | 0.17 | Why? |
| Cytochrome P-450 Enzyme System | 1 | 2018 | 144 | 0.17 | Why? |
| Oleanolic Acid | 1 | 2017 | 82 | 0.16 | Why? |
| Flavonols | 1 | 2017 | 100 | 0.16 | Why? |
| Extracellular Matrix Proteins | 1 | 2017 | 95 | 0.16 | Why? |
| Osteosarcoma | 1 | 2017 | 83 | 0.16 | Why? |
| Cytokinesis | 1 | 2016 | 3 | 0.16 | Why? |
| Skin | 3 | 2018 | 2096 | 0.16 | Why? |
| Acute Kidney Injury | 1 | 2017 | 5762 | 0.16 | Why? |
| Insulin-Like Growth Factor I | 1 | 2017 | 119 | 0.16 | Why? |
| CpG Islands | 1 | 2018 | 230 | 0.16 | Why? |
| Nicotinic Acids | 1 | 2016 | 4 | 0.16 | Why? |
| Inflammation Mediators | 2 | 2019 | 2654 | 0.16 | Why? |
| Drinking Water | 1 | 2018 | 145 | 0.16 | Why? |
| Nonlinear Dynamics | 1 | 2017 | 177 | 0.16 | Why? |
| Food | 1 | 2019 | 316 | 0.16 | Why? |
| Metabolic Networks and Pathways | 1 | 2018 | 285 | 0.15 | Why? |
| Liquid-Liquid Extraction | 1 | 2016 | 60 | 0.15 | Why? |
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 372 | 0.15 | Why? |
| Toll-Like Receptor 4 | 1 | 2019 | 390 | 0.15 | Why? |
| Biomarkers | 8 | 2019 | 23361 | 0.15 | Why? |
| Locomotion | 1 | 2017 | 130 | 0.15 | Why? |
| Stilbenes | 1 | 2017 | 113 | 0.15 | Why? |
| Organoselenium Compounds | 1 | 2017 | 123 | 0.15 | Why? |
| Guanidines | 1 | 2020 | 499 | 0.15 | Why? |
| Healthy Lifestyle | 1 | 2020 | 447 | 0.15 | Why? |
| Tissue Distribution | 1 | 2017 | 483 | 0.15 | Why? |
| Glioblastoma | 1 | 2018 | 187 | 0.15 | Why? |
| Toll-Like Receptors | 1 | 2018 | 365 | 0.15 | Why? |
| Feeding Behavior | 2 | 2018 | 1909 | 0.15 | Why? |
| Pancreas | 1 | 2019 | 398 | 0.15 | Why? |
| Disease Outbreaks | 3 | 2020 | 27595 | 0.15 | Why? |
| Male | 23 | 2020 | 367725 | 0.15 | Why? |
| Antineoplastic Agents, Phytogenic | 1 | 2017 | 183 | 0.15 | Why? |
| Cardiovascular Diseases | 1 | 2020 | 11497 | 0.15 | Why? |
| Stroke | 1 | 2019 | 8839 | 0.15 | Why? |
| Mitochondria | 2 | 2019 | 857 | 0.14 | Why? |
| Triterpenes | 1 | 2017 | 199 | 0.14 | Why? |
| Amino Acids | 1 | 2019 | 552 | 0.14 | Why? |
| Epithelial-Mesenchymal Transition | 1 | 2017 | 242 | 0.14 | Why? |
| Cardiotoxicity | 1 | 2018 | 365 | 0.14 | Why? |
| Lycopersicon esculentum | 1 | 2014 | 24 | 0.14 | Why? |
| Carbon | 1 | 2017 | 269 | 0.14 | Why? |
| Angiotensin II Type 1 Receptor Blockers | 1 | 2020 | 520 | 0.14 | Why? |
| Parkinson Disease, Secondary | 1 | 2014 | 15 | 0.14 | Why? |
| Vitamin K | 1 | 2017 | 263 | 0.14 | Why? |
| Air Pollution | 3 | 2020 | 3504 | 0.14 | Why? |
| Insulin Resistance | 2 | 2017 | 669 | 0.14 | Why? |
| Tobacco Products | 1 | 2018 | 245 | 0.14 | Why? |
| Lymphocytes | 2 | 2019 | 3056 | 0.14 | Why? |
| Silver | 1 | 2017 | 327 | 0.14 | Why? |
| Hemostasis | 1 | 2021 | 811 | 0.14 | Why? |
| Fungicides, Industrial | 1 | 2013 | 22 | 0.13 | Why? |
| Body Weight | 2 | 2018 | 1074 | 0.13 | Why? |
| Cell Movement | 1 | 2017 | 695 | 0.13 | Why? |
| Gene Frequency | 1 | 2018 | 1210 | 0.13 | Why? |
| Colonic Neoplasms | 1 | 2017 | 295 | 0.13 | Why? |
| Immune Tolerance | 1 | 2018 | 608 | 0.13 | Why? |
| Drug Resistance, Neoplasm | 1 | 2017 | 447 | 0.13 | Why? |
| Thyroid Gland | 1 | 2018 | 516 | 0.13 | Why? |
| Pandemics | 13 | 2021 | 389249 | 0.12 | Why? |
| Primary Prevention | 1 | 2020 | 778 | 0.12 | Why? |
| Consumer Behavior | 1 | 2019 | 544 | 0.12 | Why? |
| DNA Methylation | 1 | 2018 | 688 | 0.12 | Why? |
| Air Pollutants, Occupational | 1 | 2013 | 108 | 0.12 | Why? |
| Reactive Oxygen Species | 1 | 2019 | 1136 | 0.12 | Why? |
| Adenocarcinoma | 1 | 2019 | 651 | 0.12 | Why? |
| Zinc | 1 | 2020 | 817 | 0.12 | Why? |
| Dogs | 1 | 2020 | 2529 | 0.12 | Why? |
| Female | 22 | 2020 | 380317 | 0.12 | Why? |
| Risk Factors | 7 | 2020 | 71621 | 0.12 | Why? |
| Adolescent Behavior | 1 | 2018 | 400 | 0.12 | Why? |
| Enterovirus Infections | 1 | 2017 | 404 | 0.12 | Why? |
| Leukocytes | 1 | 2019 | 1046 | 0.12 | Why? |
| Lipids | 1 | 2019 | 1079 | 0.12 | Why? |
| Selenium | 1 | 2017 | 412 | 0.12 | Why? |
| Ecosystem | 1 | 2017 | 776 | 0.11 | Why? |
| NF-kappa B | 1 | 2019 | 1301 | 0.11 | Why? |
| Public Health | 1 | 2017 | 16359 | 0.11 | Why? |
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2018 | 529 | 0.11 | Why? |
| Lipid Peroxidation | 1 | 2011 | 114 | 0.11 | Why? |
| Vitamins | 1 | 2020 | 1208 | 0.11 | Why? |
| Liver Function Tests | 1 | 2018 | 1325 | 0.11 | Why? |
| Neuroimaging | 1 | 2019 | 1106 | 0.11 | Why? |
| Metformin | 1 | 2018 | 640 | 0.11 | Why? |
| Sex Characteristics | 1 | 2019 | 1120 | 0.11 | Why? |
| Limit of Detection | 1 | 2019 | 2698 | 0.11 | Why? |
| Probiotics | 1 | 2018 | 694 | 0.10 | Why? |
| Cost-Benefit Analysis | 1 | 2020 | 2259 | 0.10 | Why? |
| Metal Nanoparticles | 1 | 2017 | 771 | 0.10 | Why? |
| Gastrointestinal Tract | 1 | 2018 | 1113 | 0.10 | Why? |
| Interleukin-10 | 1 | 2017 | 1409 | 0.10 | Why? |
| Athletes | 1 | 2018 | 1047 | 0.10 | Why? |
| Recombinant Proteins | 1 | 2020 | 3786 | 0.10 | Why? |
| Triazoles | 1 | 2013 | 440 | 0.10 | Why? |
| Particle Size | 3 | 2019 | 1052 | 0.09 | Why? |
| Immunologic Memory | 1 | 2021 | 3362 | 0.09 | Why? |
| Drug Carriers | 3 | 2019 | 590 | 0.09 | Why? |
| Protein Kinase Inhibitors | 1 | 2018 | 1585 | 0.09 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.09 | Why? |
| Prevalence | 2 | 2020 | 25773 | 0.09 | Why? |
| Heparin | 1 | 2021 | 2600 | 0.09 | Why? |
| Single-Cell Analysis | 1 | 2018 | 2450 | 0.08 | Why? |
| Cardiomyopathies | 1 | 2017 | 997 | 0.08 | Why? |
| Carbon Monoxide | 2 | 2019 | 167 | 0.08 | Why? |
| Body Mass Index | 2 | 2018 | 4306 | 0.08 | Why? |
| Equipment Design | 1 | 2018 | 3095 | 0.08 | Why? |
| Vitamin D Deficiency | 1 | 2020 | 1782 | 0.08 | Why? |
| Smoking | 1 | 2020 | 3358 | 0.08 | Why? |
| Liver | 2 | 2018 | 4007 | 0.08 | Why? |
| Anticoagulants | 2 | 2019 | 9563 | 0.08 | Why? |
| Monocytes | 1 | 2019 | 2978 | 0.08 | Why? |
| Metabolic Syndrome | 1 | 2014 | 810 | 0.08 | Why? |
| Melanoma | 1 | 2017 | 1229 | 0.08 | Why? |
| Thrombophilia | 1 | 2019 | 1935 | 0.08 | Why? |
| Seasons | 1 | 2019 | 4071 | 0.08 | Why? |
| Italy | 3 | 2020 | 38444 | 0.08 | Why? |
| Disease Susceptibility | 1 | 2019 | 4002 | 0.07 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2019 | 3607 | 0.07 | Why? |
| Vitamin D | 1 | 2020 | 2904 | 0.07 | Why? |
| Odds Ratio | 1 | 2017 | 5861 | 0.07 | Why? |
| Patient Safety | 1 | 2020 | 4885 | 0.07 | Why? |
| Polymers | 2 | 2019 | 507 | 0.07 | Why? |
| Computer Simulation | 1 | 2019 | 4982 | 0.07 | Why? |
| World Health Organization | 1 | 2017 | 4213 | 0.07 | Why? |
| Skin Neoplasms | 1 | 2017 | 1679 | 0.07 | Why? |
| Politics | 1 | 2017 | 1824 | 0.06 | Why? |
| Blood Coagulation Disorders | 1 | 2017 | 2040 | 0.06 | Why? |
| Sleep Apnea, Obstructive | 1 | 2011 | 668 | 0.06 | Why? |
| Kidney | 1 | 2017 | 3648 | 0.06 | Why? |
| Biological Products | 1 | 2017 | 2331 | 0.06 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.06 | Why? |
| Substance-Related Disorders | 1 | 2017 | 2038 | 0.06 | Why? |
| Continuous Positive Airway Pressure | 1 | 2011 | 1187 | 0.06 | Why? |
| Exercise | 2 | 2020 | 6771 | 0.06 | Why? |
| Aerosols | 1 | 2018 | 5393 | 0.06 | Why? |
| Interleukin-6 | 2 | 2017 | 7522 | 0.06 | Why? |
| Brain | 1 | 2019 | 5133 | 0.06 | Why? |
| Case-Control Studies | 2 | 2018 | 17671 | 0.06 | Why? |
| Disease Models, Animal | 1 | 2019 | 10998 | 0.05 | Why? |
| Heart Diseases | 1 | 2018 | 3503 | 0.05 | Why? |
| Adult | 8 | 2019 | 244371 | 0.05 | Why? |
| Mutation | 1 | 2021 | 12376 | 0.05 | Why? |
| Protein Carbonylation | 1 | 2019 | 23 | 0.05 | Why? |
| Dinitrochlorobenzene | 1 | 2019 | 2 | 0.05 | Why? |
| Hyaluronan Synthases | 1 | 2019 | 5 | 0.05 | Why? |
| Models, Theoretical | 1 | 2019 | 6659 | 0.05 | Why? |
| HT29 Cells | 1 | 2019 | 108 | 0.05 | Why? |
| Arsenic | 1 | 2020 | 85 | 0.05 | Why? |
| beta Carotene | 1 | 2019 | 5 | 0.05 | Why? |
| Picrates | 1 | 2019 | 12 | 0.05 | Why? |
| Phenylenediamines | 1 | 2019 | 19 | 0.05 | Why? |
| Epidemics | 1 | 2020 | 6407 | 0.05 | Why? |
| Drug Liberation | 1 | 2019 | 141 | 0.05 | Why? |
| Catalase | 1 | 2019 | 97 | 0.05 | Why? |
| Drug Screening Assays, Antitumor | 1 | 2019 | 138 | 0.05 | Why? |
| Marine Toxins | 1 | 2018 | 8 | 0.05 | Why? |
| Cadmium Poisoning | 1 | 2018 | 2 | 0.05 | Why? |
| Antimetabolites, Antineoplastic | 1 | 2019 | 99 | 0.05 | Why? |
| Molecular Weight | 1 | 2019 | 249 | 0.05 | Why? |
| Respiratory Tract Infections | 1 | 2020 | 6817 | 0.05 | Why? |
| Core Binding Factor Alpha 3 Subunit | 1 | 2018 | 9 | 0.05 | Why? |
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2018 | 13 | 0.05 | Why? |
| Activation, Metabolic | 1 | 2018 | 6 | 0.05 | Why? |
| Microscopy, Electron, Scanning | 1 | 2019 | 221 | 0.05 | Why? |
| G1 Phase Cell Cycle Checkpoints | 1 | 2018 | 26 | 0.05 | Why? |
| Mice, Hairless | 1 | 2017 | 2 | 0.05 | Why? |
| Lipolysis | 1 | 2017 | 12 | 0.05 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.05 | Why? |
| Hydroxylation | 1 | 2017 | 8 | 0.05 | Why? |
| Enzyme Induction | 1 | 2018 | 89 | 0.05 | Why? |
| Chorioallantoic Membrane | 1 | 2017 | 7 | 0.05 | Why? |
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2018 | 28 | 0.05 | Why? |
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2018 | 45 | 0.05 | Why? |
| Biological Availability | 1 | 2019 | 388 | 0.05 | Why? |
| Cyanobacteria | 1 | 2018 | 53 | 0.05 | Why? |
| Microscopy, Electron | 1 | 2021 | 830 | 0.05 | Why? |
| Thrombosis | 1 | 2021 | 7504 | 0.05 | Why? |
| Chemical Warfare Agents | 1 | 2017 | 9 | 0.04 | Why? |
| Actin Cytoskeleton | 1 | 2017 | 30 | 0.04 | Why? |
| Aromatase Inhibitors | 1 | 2018 | 45 | 0.04 | Why? |
| Hormones | 1 | 2018 | 66 | 0.04 | Why? |
| Nitrogen Oxides | 1 | 2018 | 72 | 0.04 | Why? |
| Lipogenesis | 1 | 2017 | 49 | 0.04 | Why? |
| Mustard Gas | 1 | 2017 | 14 | 0.04 | Why? |
| Arsenicals | 1 | 2017 | 40 | 0.04 | Why? |
| Thyroid Function Tests | 1 | 2018 | 200 | 0.04 | Why? |
| Phytoestrogens | 1 | 2017 | 12 | 0.04 | Why? |
| Biphenyl Compounds | 1 | 2019 | 249 | 0.04 | Why? |
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 96 | 0.04 | Why? |
| Tumor Cells, Cultured | 1 | 2017 | 254 | 0.04 | Why? |
| MCF-7 Cells | 1 | 2017 | 199 | 0.04 | Why? |
| Glutathione | 1 | 2019 | 280 | 0.04 | Why? |
| Estrogen Receptor Modulators | 1 | 2017 | 27 | 0.04 | Why? |
| Virus Cultivation | 1 | 2021 | 579 | 0.04 | Why? |
| Luteolin | 1 | 2017 | 70 | 0.04 | Why? |
| Chick Embryo | 1 | 2017 | 249 | 0.04 | Why? |
| Tumor Microenvironment | 1 | 2019 | 264 | 0.04 | Why? |
| Inventions | 1 | 2021 | 372 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2018 | 22971 | 0.04 | Why? |
| Cell Adhesion | 1 | 2017 | 230 | 0.04 | Why? |
| DNA Repair | 1 | 2017 | 114 | 0.04 | Why? |
| Receptors, Estrogen | 1 | 2017 | 171 | 0.04 | Why? |
| Age Factors | 1 | 2018 | 21039 | 0.04 | Why? |
| Cytokines | 1 | 2019 | 15010 | 0.04 | Why? |
| Dust | 1 | 2018 | 178 | 0.04 | Why? |
| Neovascularization, Physiologic | 1 | 2017 | 160 | 0.04 | Why? |
| Cell Cycle | 1 | 2017 | 329 | 0.04 | Why? |
| Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 382 | 0.04 | Why? |
| Iran | 2 | 2019 | 5467 | 0.04 | Why? |
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2021 | 624 | 0.04 | Why? |
| Cell Transformation, Neoplastic | 1 | 2017 | 191 | 0.04 | Why? |
| Microscopy, Electron, Transmission | 1 | 2018 | 605 | 0.04 | Why? |
| Drug Resistance, Multiple | 1 | 2017 | 156 | 0.04 | Why? |
| Urea | 1 | 2017 | 228 | 0.04 | Why? |
| Middle Aged | 7 | 2019 | 270681 | 0.04 | Why? |
| Receptors, Androgen | 1 | 2018 | 212 | 0.04 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.04 | Why? |
| Nerve Tissue Proteins | 1 | 2018 | 319 | 0.04 | Why? |
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 245 | 0.04 | Why? |
| Nanofibers | 1 | 2017 | 143 | 0.04 | Why? |
| Apoptosis | 2 | 2017 | 2335 | 0.04 | Why? |
| Dieldrin | 1 | 2014 | 1 | 0.04 | Why? |
| Maneb | 1 | 2014 | 2 | 0.04 | Why? |
| Inhibitory Concentration 50 | 1 | 2018 | 907 | 0.04 | Why? |
| Paraquat | 1 | 2014 | 15 | 0.04 | Why? |
| Nitrogen Dioxide | 1 | 2018 | 488 | 0.04 | Why? |
| Pyrethrins | 1 | 2014 | 28 | 0.04 | Why? |
| Random Allocation | 1 | 2017 | 773 | 0.03 | Why? |
| Vaccination | 1 | 2020 | 19050 | 0.03 | Why? |
| Receptors, G-Protein-Coupled | 1 | 2017 | 309 | 0.03 | Why? |
| Thyroid Diseases | 1 | 2018 | 285 | 0.03 | Why? |
| Inhalation Exposure | 1 | 2018 | 405 | 0.03 | Why? |
| Russia | 1 | 2018 | 989 | 0.03 | Why? |
| Angiogenesis Inhibitors | 1 | 2017 | 395 | 0.03 | Why? |
| Proteasome Inhibitors | 1 | 2014 | 127 | 0.03 | Why? |
| Wine | 1 | 2013 | 57 | 0.03 | Why? |
| Treatment Outcome | 1 | 2020 | 51732 | 0.03 | Why? |
| Organ Specificity | 1 | 2017 | 1070 | 0.03 | Why? |
| Polyethylene Glycols | 1 | 2017 | 574 | 0.03 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.03 | Why? |
| Lipid Metabolism | 1 | 2017 | 572 | 0.03 | Why? |
| Tandem Mass Spectrometry | 1 | 2019 | 1031 | 0.03 | Why? |
| Thyroid Neoplasms | 1 | 2018 | 422 | 0.03 | Why? |
| Cell Membrane | 1 | 2017 | 743 | 0.03 | Why? |
| Respiration | 1 | 2018 | 729 | 0.03 | Why? |
| Respiratory Tract Diseases | 1 | 2020 | 1061 | 0.03 | Why? |
| Child | 2 | 2019 | 70012 | 0.03 | Why? |
| Neurons | 1 | 2018 | 864 | 0.03 | Why? |
| Diet, Reducing | 1 | 2011 | 38 | 0.03 | Why? |
| Creatinine | 1 | 2017 | 1443 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.03 | Why? |
| Agriculture | 1 | 2013 | 367 | 0.03 | Why? |
| Drug Overdose | 1 | 2017 | 583 | 0.03 | Why? |
| Microbial Sensitivity Tests | 1 | 2019 | 2886 | 0.03 | Why? |
| Polysomnography | 1 | 2011 | 296 | 0.02 | Why? |
| Young Adult | 2 | 2019 | 93724 | 0.02 | Why? |
| Administration, Oral | 1 | 2017 | 2340 | 0.02 | Why? |
| Antioxidants | 1 | 2019 | 1593 | 0.02 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 1573 | 0.02 | Why? |
| Cognition | 1 | 2017 | 1394 | 0.02 | Why? |
| Anti-Infective Agents | 1 | 2019 | 1766 | 0.02 | Why? |
| Adaptive Immunity | 1 | 2019 | 2585 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2021 | 3388 | 0.02 | Why? |
| Cities | 1 | 2018 | 4937 | 0.02 | Why? |
| Protein Domains | 1 | 2017 | 6563 | 0.02 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2014 | 2483 | 0.02 | Why? |
| Adolescent | 3 | 2019 | 86841 | 0.02 | Why? |
| Cell Line | 1 | 2019 | 12040 | 0.02 | Why? |
| Combined Modality Therapy | 1 | 2011 | 3395 | 0.01 | Why? |
| Europe | 1 | 2018 | 12702 | 0.01 | Why? |
| Occupational Health | 1 | 2017 | 3965 | 0.01 | Why? |
| Immunity, Innate | 1 | 2019 | 6570 | 0.01 | Why? |
| Pneumonia | 1 | 2020 | 5652 | 0.01 | Why? |
| Asthma | 1 | 2018 | 4383 | 0.01 | Why? |
| Disease Progression | 1 | 2017 | 13580 | 0.01 | Why? |
| Mice | 1 | 2017 | 21357 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |